Literature DB >> 30015264

Predictors of severe relapse in pregnant women with psychotic or bipolar disorders.

Clare L Taylor1, Matthew Broadbent2, Mizanur Khondoker3, Robert J Stewart4, Louise M Howard5.   

Abstract

Pregnancy in women with severe mental illness is associated with adverse outcomes for mother and infant. There are limited data on prevalence and predictors of relapse in pregnancy. A historical cohort study using anonymised comprehensive electronic health records from secondary mental health care linked with national maternity data was carried out. Women with a history of serious mental illness who were pregnant (2007-2011), and in remission at the start of pregnancy, were studied; severe relapse was defined as admission to acute care or self-harm. Predictors of relapse were analysed using random effects logistic regression to account for repeated measures in women with more than one pregnancy in the study period. In 454 pregnancies (389 women) there were 58 (24%) relapses in women with non-affective psychoses and 25 (12%) in women with affective psychotic or bipolar disorders. Independent predictors of relapse included non-affective psychosis (adjusted OR = 2.03; 95% CI = 1.16-3.54), number of recent admissions (1.37; 1.03-1.84), recent self-harm (2.24; 1.15-4.34), substance use (2.15; 1.13-4.08), smoking (2.52; 1.26-5.02) and non-white ethnicity (black ethnicity: 2.37; 1.23-4.57, mixed/other ethnicity: 2.94; 1.32-6.56). Women on no regular medication throughout first trimester were also at greater risk of relapse in pregnancy (1.99; 1.05-3.75). There was no interaction between severity of illness and medication status as relapse predictors. Therefore, women with non-affective psychosis and higher number of recent acute admissions are at significant risk of severe relapse in pregnancy. Continuation of medication in women with severe mental illness who become pregnant may be protective.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Bipolar; Medication; Pregnancy; Psychosis; Relapse

Mesh:

Substances:

Year:  2018        PMID: 30015264     DOI: 10.1016/j.jpsychires.2018.06.019

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  8 in total

1.  Long-Acting Injectable Antipsychotic Use During Pregnancy: A Brief Review and Concise Guide for Clinicians.

Authors:  Sarah A Reinstein; Jessica Cosgrove; Tara Malekshahi; Kristina M Deligiannidis
Journal:  J Clin Psychiatry       Date:  2020-11-24       Impact factor: 4.384

2.  Antipsychotic utilization patterns in pregnant women with psychotic disorders: a 16-year population-based cohort study.

Authors:  Jenny Wai Yiu Law; Joe Kwun Nam Chan; Corine Sau Man Wong; Eric Yu Hai Chen; Wing Chung Chang
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-07-06       Impact factor: 5.270

3.  Characterization of Depressive Symptom Trajectories in Women between Childbirth and Diagnosis.

Authors:  Natalia Chechko; Susanne Stickel; Elena Losse; Aliaksandra Shymanskaya; Ute Habel
Journal:  J Pers Med       Date:  2022-03-28

4.  Perinatal mental health: a review of progress and challenges.

Authors:  Louise M Howard; Hind Khalifeh
Journal:  World Psychiatry       Date:  2020-10       Impact factor: 49.548

5.  An Analysis of Cellular Communication Network Factor Proteins as Candidate Mediators of Postpartum Psychosis Risk.

Authors:  William Davies
Journal:  Front Psychiatry       Date:  2019-11-26       Impact factor: 4.157

6.  An evaluation of symptom domains in the 2 years before pregnancy as predictors of relapse in the perinatal period in women with severe mental illness.

Authors:  Sharvari Khapre; Robert Stewart; Clare Taylor
Journal:  Eur Psychiatry       Date:  2021-03-19       Impact factor: 5.361

7.  Birth without intervention in women with severe mental illness: cohort study.

Authors:  Clare Taylor; Robert Stewart; Rod Gibson; Dharmintra Pasupathy; Hitesh Shetty; Louise Howard
Journal:  BJPsych Open       Date:  2022-02-24

Review 8.  mHealth Solutions for Perinatal Mental Health: Scoping Review and Appraisal Following the mHealth Index and Navigation Database Framework.

Authors:  Benedetta Spadaro; Nayra A Martin-Key; Erin Funnell; Sabine Bahn
Journal:  JMIR Mhealth Uhealth       Date:  2022-01-17       Impact factor: 4.773

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.